Please login to the form below

Not currently logged in
Email:
Password:

Chugai Pharma

This page shows the latest Chugai Pharma news and features for those working in and with pharma, biotech and healthcare.

Chugai gains FDA breakthrough status for rare CNS treatment

Chugai gains FDA breakthrough status for rare CNS treatment

Adds to company's BTD roll-call. The FDA has granted Breakthrough Therapy Designation to Chugai’s satralizumab, a treatment currently in phase 3 for the rare CNS disorders neuromyelitis optica ... Satralizumab is a recycling antibody created via

Latest news

  • Chugai soars on Roche buyout rumours Chugai soars on Roche buyout rumours

    Shares in Japanese pharma company Chugai are riding high amid growing speculation that Roche is poised to buy out the firm. ... price being bandied around, while others say Roche sees benefit on outright ownership of Chugai's portfolio.

  • Chugai sets up antibody research company in Singapore

    Chugai Pharmabody Research will focus on generating new antibody drugs. Japanese pharma company Chugai is to set up a new research company based in Singapore. ... Chugai is putting 1.5m Singapore dollars (approximately $1.2m) into establishing the company

  • A rush for sweet success

    RYZOLTTM (Purdue Pharma). Chronic pain. US. Cyanocobalamin. PreHistin (Cobalis Corp). Allergy. ... The GLP-1 pipeline includes five phase III compounds – albiglutide (Syncria, GSK, Human Genome Sciences), LY2189265 (Eli Lilly), taspoglutide (Roche,

  • Chugai shares continue decline

    Shares in Rocheís Japanese subsidiary, Chugai, fall to a two-year low over concerns that the company may not meet earnings and sales targets. ... targets. Shares in Chugai fell 3.7 per cent (JPY 68) to bottom out at JPY 1, 750, the lowest since July 2005

  • Chugai profits may exceed forecast

    Chugai, the Japanese subsidiary of Swiss pharmaceutical company Roche, may exceed its own profits forecast. ... The analysts said that Epogin Q1 FY07 sales were not as badly affected by Nesp as Chugai first thought.

More from news
Approximately 1 fully matching, plus 7 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Chugai appoints Ruth Currie as MD of its UK business Chugai appoints Ruth Currie as MD of its UK business

    She replaces John Halls, who has been promoted. Chugai Pharmaceuticals has promoted Ruth Currie to managing director of its UK business. ... In her new role, Currie will oversee all UK commercial operations of Chugai, which has been a subsidiary of Roche

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
huumun formerly PharmiWeb Solutions

huumun, is a digital transformation business. For us, digital transformation means using digital technologies, not just to turn an existing...

Latest intelligence

Article: Like, Like, Like: Harnessing the power of social media insights
...
Its Know Your Numbers week
Do you know yours?...
What is changing in mental health and dementia care?
Paul Midgley, of Wilmington Healthcare, takes a look at the NHS Long Term Plan's bid to transform mental health and dementia services...

Infographics